Telemedicine for TB Follow-Up Care in Rural Cambodia
Tuberculosis treatment can last six months or longer, and the period after diagnosis is often the hardest for patients living far from a hospital. A missed appointment may mean lost wages, transport costs, delayed management of side effects, or an interruption to medicines. In rural Cambodia, digital health can make routine follow-up more accessible while keeping essential examinations and laboratory tests in local facilities.
A practical telemedicine service would connect village patients, health-centre staff, district hospitals and tuberculosis specialists. It could combine scheduled phone calls, secure messaging, video consultations where connectivity permits, and digital records that track symptoms, prescriptions, test results and missed visits. The aim is continuity of care rather than replacing face-to-face treatment.
For ICTD-ASP, this is a strong example of how technology partnerships can support public health and reduce geographic inequality. Cambodia’s Ministry of Health, telecommunications providers, development agencies, local organisations and clinical networks could develop a model that is affordable, interoperable and suitable for expansion across the Asia-Pacific region.
Why follow-up care needs a digital layer
Tuberculosis follow-up involves several recurring tasks: checking whether medicines are taken correctly, identifying adverse reactions, reviewing sputum or other test results, supporting household infection control, and deciding when a patient needs referral. These steps do not always require a specialist to be physically present. A trained health worker can conduct a structured check-in and escalate concerns through a teleconsultation.
Digital contact is especially valuable after the initial treatment plan has been established. Patients may be stable but still need regular support, and a brief call can prevent a minor concern from becoming a treatment interruption. Where a patient reports jaundice, severe rash, breathing difficulty, confusion or other warning signs, the platform should trigger urgent in-person assessment rather than offering remote reassurance.
A telemedicine programme must therefore be designed as a clinical pathway, not a video-chat service. It should define who contacts the patient, how often, which symptoms require escalation, where tests are performed, and how clinicians document decisions.
Designing for Cambodia’s rural conditions
Cambodia’s rural communities vary in mobile coverage, electricity reliability, language, literacy and household income. Some patients may share one basic phone with family members, while others may use a smartphone but have limited data or unstable connectivity. A service that depends entirely on high-bandwidth video would exclude the people most likely to face access barriers.
A layered model is more suitable. Voice calls and SMS can support reminders and symptom screening; smartphone applications can offer Khmer-language education and image-based instructions; video can be reserved for cases that benefit from visual assessment or specialist review. Health-centre workers can provide a trusted local point for digital consultations, charging devices and completing referrals.
The design should also account for seasonal work, flooding, migration and transport patterns. Appointment windows may need to include evenings, and patients should be able to nominate a caregiver or community health worker when appropriate. Offline data capture can allow staff to record information during a visit and synchronise it when a connection becomes available.
A safe clinical workflow
At enrolment, the patient’s consent, preferred contact method, treatment regimen, emergency contact and local referral facility should be recorded. The system can then generate reminders for medicine collection, laboratory testing and scheduled reviews. A simple dashboard can flag missed contacts, symptoms, treatment interruptions and results that need clinician attention.
The follow-up script should be short enough for routine use but clinically meaningful. It might cover medicine access, adherence, nausea, hearing or vision changes, skin reactions, breathing symptoms, weight changes, household exposure and social barriers. Digital adherence tools, such as automated reminders or electronic pillbox data, may assist some patients, but they should support human contact rather than create surveillance without support.
Laboratory services remain central. Sputum collection, molecular testing, chest imaging and assessment for drug-resistant tuberculosis generally require physical facilities and trained personnel. Telemedicine can coordinate these services, transmit results securely and bring specialist advice closer to the patient; it cannot replace diagnostic quality assurance.
Trust, privacy and inclusion
Patients may hesitate to discuss tuberculosis because of stigma, fear of disclosure or concern about losing work. Calls should use neutral language, protect privacy and avoid identifying the diagnosis when a shared phone is used. Patients should understand what information is collected, who can see it, how long it is retained and what happens if they decline digital contact.
Cambodia’s programme should establish role-based access, secure authentication, audit trails, device protection and a process for handling lost phones. Consent should be available in clear Khmer and relevant local languages, with verbal consent documented where literacy is limited. Community organisations can help test messages so they are respectful, understandable and appropriate for different groups.
Australian experience offers useful reference points, though it should not be copied without adaptation. People in Australia are accustomed to smartphone messaging, online appointments and digital prescriptions, while Medicare-funded telehealth and the My Health Record environment have made remote care more familiar. Privacy obligations under the Privacy Act 1988 and the My Health Records Act 2012 also illustrate the importance of clear governance when health data moves between organisations.
Partnerships that can make the model viable
A sustainable pilot would need more than a technology vendor. The Ministry of Health could set clinical standards and reporting requirements; provincial and district services could manage referrals; telecommunications companies could contribute connectivity or subsidised data; universities could evaluate outcomes; and civil-society groups could support adherence, stigma reduction and patient feedback.
ICTD-ASP can help convene these stakeholders and align technical assistance with investment. A shared architecture should use open standards where possible, connect with existing health information systems, and avoid locking Cambodia into a platform that cannot exchange data with laboratory, pharmacy or national reporting systems. Procurement should consider training, maintenance, cybersecurity and local support over the full life of the service.
Financing should measure value in health and access terms. Relevant indicators include completed follow-ups, treatment interruption rates, time from warning sign to clinical review, successful laboratory referrals, patient-reported confidence and cost per patient retained in care. Disaggregating results by province, gender, age, disability, phone access and distance from a facility can reveal who is being left out.
Comparing delivery options and scaling responsibly
The right combination of tools will differ by province and patient group. A small pilot should test several channels rather than assume that the most sophisticated option is the best. It should also include a comparison group or baseline, independent ethics oversight and a plan for acting on adverse events.
| Delivery option | Best use | Main limitation | Safeguard |
|---|---|---|---|
| Voice calls | Routine symptom checks and adherence support | Limited visual information and privacy on shared phones | Confirm identity and use a structured script |
| SMS reminders | Appointment and medicine prompts | Messages may be missed or seen by others | Use discreet wording and opt-in consent |
| Video consultation | Specialist review and complex discussions | Requires data, a suitable device and stable connectivity | Offer a phone alternative and local health-worker support |
| Health-centre assisted visit | Patients with limited literacy or digital access | Requires staff time and facility availability | Train staff and provide clear referral protocols |
| Offline-enabled mobile system | Data capture in low-connectivity areas | Synchronisation and device security risks | Encrypt data and monitor failed uploads |
Scaling should follow evidence, not enthusiasm. Begin with a limited number of districts, map network and facility readiness, train health workers, and run the service alongside existing tuberculosis care. After several treatment cycles, review clinical outcomes, patient experience, equity data and operating costs before expanding.
For an immediate next step, participating partners should select two rural districts and complete a joint readiness assessment covering connectivity, staff capacity, referral facilities, privacy controls and patient needs.